Screener
Vaxcyte, Inc. PCVX Business Segments — Net loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Loss from operations | (345,850) | (180,793) |
| Other income, net: | ||
| Interest income | 26,610 | 32,935 |
| Other income (expense) | (1,382) | 7,140 |
| Total other income, net | 25,228 | 40,075 |
| Net loss | $(320,622) | $(140,718) |
| Net loss per share, basic and diluted | $(2.30) | $(1.04) |
| Weighted-average shares outstanding, basic and diluted | 139,506,680 | 135,690,949 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s business segments — net loss?
- Vaxcyte, Inc. (PCVX) reported business segments — net loss of -$320.62M in Q1 2026.
- How has Vaxcyte, Inc.'s business segments — net loss changed year-over-year?
- Vaxcyte, Inc.'s business segments — net loss decreased by 127.8% year-over-year, from -$140.72M to -$320.62M.
- What is the long-term trend for Vaxcyte, Inc.'s business segments — net loss?
- Over 3 years (2022 to 2025), Vaxcyte, Inc.'s business segments — net loss has grown at a 50.8% compound annual growth rate (CAGR), from -$223.49M to -$766.63M.
- What does business segments — net loss mean?
- This metric represents the negative bottom-line result for the business segment after accounting for all operating expenses and non-operating items. It indicates the extent to which the segment's costs exceed its revenues during a specific period. For early-stage companies, this is a key indicator of the capital intensity required to reach commercialization.
Ask your AI about Vaxcyte, Inc.'s business segments — net loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude